Dall, L. B., Deleuran, B., Østergaard, L. J., Mardahl, M., Denton, P. W.
& Nejsum, P. (2022).
Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus.
Lupus,
31(4), 415-423.
https://doi.org/10.1177/09612033221080548
Whitehead, B., Christiansen, S.
, Østergaard, L. & Nejsum, P. (2022).
Helminths and COVID-19 susceptibility, disease progression, and vaccination efficacy.
Trends in Parasitology,
38(4), 277-279.
https://doi.org/10.1016/j.pt.2022.01.007
Brandt, C. B., Fonager, S. V., Haskó, J., Helmig, R. B., Degn, S., Bolund, L., Jessen, N., Lin, L. & Luo, Y. (2022).
HIF1A Knockout by Biallelic and Selection-Free CRISPR Gene Editing in Human Primary Endothelial Cells with Ribonucleoprotein Complexes.
Biomolecules,
13(1), Article 23.
https://doi.org/10.3390/biom13010023
Yiu, G.
, Rasmussen, T. K., Tsai, B. L., Diep, V. K., Haddon, D. J., Tsoi, J., Miller, G. D., Comin-Anduix, B.
, Deleuran, B., Crooks, G. M. & Utz, P. J. (2022).
High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
Frontiers in Immunology,
13, Article 833636.
https://doi.org/10.3389/fimmu.2022.833636
Laursen, T. L., Bossen, L., Pihl, R., Troldborg, A., Sandahl, T. D., Hansen, A. G., Folserass, T., Vesterhus, M.
, Gronbaek, H. & Thiel, S. (2022).
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases.
Journal of clinical and translational hepatology,
10(5), 796–802.
https://doi.org/10.14218/JCTH.2021.00515
Fonseca, A. S., Jørgensen, A. K., Larsen, B. X., Moser-Johansen, M., Flachs, E. M., Ebbehøj, N. E., Bønløkke, J. H., Østergaard, T. O., Bælum, J., Sherson, D. L.
, Schlünssen, V., Meyer, H. W. & Jensen, K. A. (2022).
Historical Asbestos Measurements in Denmark-A National Database.
International Journal of Environmental Research and Public Health,
19(2), Article 643.
https://doi.org/10.3390/ijerph19020643
Bregnhøj, A., Thuesen, K. K. H., Emmanuel, T., Litman, T., Grek, C. L., Ghatnekar, G. S.
, Johansen, C. & Iversen, L. (2022).
HSP90 inhibitor RGRN-305 for oral treatment of plaque type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study.
British Journal of Dermatology,
186(5), 861-874.
https://doi.org/10.1111/bjd.20880
Cen, H. H., Hussein, B., Botezelli, J. D., Wang, S., Zhang, J. A., Noursadeghi, N.
, Jessen, N., Rodrigues, B., Timmons, J. A. & Johnson, J. D. (2022).
Human and mouse muscle transcriptomic analyses identify insulin receptor mRNA downregulation in hyperinsulinemia-associated insulin resistance.
The FASEB Journal,
36(1), Article e22088.
https://doi.org/10.1096/fj.202100497RR
Peng, R., Wang, C. K., Wang-Kan, X.
, Idorn, M., Kjær, M., Zhou, F. Y., Fiil, B. K., Timmermann, F., Orozco, S. L., McCarthy, J., Leung, C. S., Lu, X., Bagola, K., Rehwinkel, J., Oberst, A., Maelfait, J.
, Paludan, S. R. & Gyrd-Hansen, M. (2022).
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
EMBO Reports,
23(12), Article e55839.
https://doi.org/10.15252/embr.202255839
Kirk, F. T., Munk, D. E., Ek, J., Birk Møller, L.
, Bendixen Thorup, M., Hvid Danielsen, E., Vilstrup, H., Ott, P. & Damgaard Sandahl, T. (2022).
Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years: Case Report.
Frontiers in Neurology,
13, 957794.
https://doi.org/10.3389/fneur.2022.957794
AS Henning, M., Hother, C. E., Banasik, K., Ibler, K. S., Rye Ostrowski, S.
, Erikstrup, C., Nielsen, K. R., Ullum, H., Hjalgrim, H., Hansen, T. F.
, Kaspersen, K. A., Sørensen, B. S., Sækmose, S. G., Jemec, G. B. E. & Pedersen, O. B. (2022).
Hyperhidrosis and human leucocyte antigens in the Danish Blood Donor Study.
Scandinavian Journal of Immunology,
95(5), Article e13150.
https://doi.org/10.1111/sji.13150
Henning, M. A. S., Ibler, K. S., Ostrowski, S. R.
, Erikstrup, C., Nielsen, K. R., Bruun, M. T., Hjalgrim, H., Ullum, H., Didriksen, M.
, Dinh, K. M., Rostgaard, K., Pedersen, O. B. & Jemec, G. B. (2022).
Hyperhidrosis and the risk of being treated for skin infections.
Journal of Dermatological Treatment,
33(4), 2263-2269.
https://doi.org/10.1080/09546634.2021.1944971
Brent, M. B., Emmanuel, T., Simonsen, U., Brüel, A. & Thomsen, J. S. (2022).
Hypobaric hypoxia deteriorates bone mass and strength in mice.
Bone,
154, Article 116203.
https://doi.org/10.1016/j.bone.2021.116203
Glud, E. N., Rasmussen, M., Zhang, Y., Mandrup, O. A., Salachan, P. V.
, Borre, M., Sørensen, K. D. & Howard, K. A. (2022).
Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design.
British Journal of Cancer,
127(12), 2186-2197.
https://doi.org/10.1038/s41416-022-01994-1
Taha, Z., Arulanandam, R., Maznyi, G., Godbout, E.
, Carter-Timofte, M. E., Kurmasheva, N., Reinert, L. S., Chen, A., Crupi, M. J. F., Boulton, S., Laroche, G., Phan, A., Rezaei, R., Alluqmani, N., Jirovec, A., Acal, A., Brown, E. E. F., Singaravelu, R., Petryk, J. ... Diallo, J.-S. (2022).
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Molecular Therapy,
30(9), 2998-3016.
https://doi.org/10.1016/j.ymthe.2022.04.025
Griffante, G., Hewelt-Belka, W., Albano, C., Gugliesi, F., Pasquero, S., Castillo Pacheco, S. F., Bajetto, G., Porporato, P. E., Mina, E., Vallino, M.
, Krapp, C., Jakobsen, M. R., Purdy, J., von Einem, J., Landolfo, S., Dell'Oste, V. & Biolatti, M. (2022).
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection.
mBio,
13(3), e0043522.
https://doi.org/10.1128/mbio.00435-22